Y
Yu Rim Lee
Researcher at Kyungpook National University Hospital
Publications - 64
Citations - 1147
Yu Rim Lee is an academic researcher from Kyungpook National University Hospital. The author has contributed to research in topics: Medicine & Hepatocellular carcinoma. The author has an hindex of 13, co-authored 50 publications receiving 551 citations. Previous affiliations of Yu Rim Lee include Kyungpook National University.
Papers
More filters
Journal ArticleDOI
Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma
Yu Rim Lee,Gyeonghwa Kim,Won Young Tak,Se Young Jang,Young Oh Kweon,Jung Gil Park,Hye Won Lee,Young Seok Han,Jae Min Chun,Soo-Young Park,Keun Hur +10 more
TL;DR: This study has provided strong evidence that circulating exosomal ncRNAs (miRNA‐21 and lncRNA‐ATB) are novel prognostic markers and therapeutic targets for HCC.
Journal ArticleDOI
Federated learning for predicting clinical outcomes in patients with COVID-19.
Ittai Dayan,Holger R. Roth,Aoxiao Zhong,Ahmed Harouni,Amilcare Gentili,Anas Z. Abidin,Andrew Liu,Anthony Costa,Bradford J. Wood,Chien-Sung Tsai,Chih-Hung Wang,Chun-Nan Hsu,C. K. Lee,Peiying Ruan,Daguang Xu,Dufan Wu,Eddie Huang,Felipe Kitamura,Griffin Lacey,Gustavo César de Antônio Corradi,Gustavo Nino,Hao-Hsin Shin,Hirofumi Obinata,Hui Ren,Jason C. Crane,Jesse Tetreault,Jiahui Guan,John Garrett,Joshua D. Kaggie,Jung Gil Park,Keith J. Dreyer,Krishna Juluru,Kristopher Kersten,Marcio Aloisio Bezerra Cavalcanti Rockenbach,Marius George Linguraru,Marius George Linguraru,Masoom A. Haider,Masoom A. Haider,Meena AbdelMaseeh,Nicola Rieke,Pablo F. Damasceno,Pedro Mário Cruz e Silva,Pochuan Wang,Sheng Xu,Shuichi Kawano,Sira Sriswasdi,Soo-Young Park,Thomas M. Grist,Varun Buch,Watsamon Jantarabenjakul,Watsamon Jantarabenjakul,Weichung Wang,Won Young Tak,Xiang Li,Xihong Lin,Young Joon Kwon,Abood Quraini,Andrew Feng,Andrew N. Priest,Baris Turkbey,Benjamin S. Glicksberg,Bernardo Bizzo,Byung Seok Kim,Carlos Tor-Díez,Chia-Cheng Lee,Chia-Jung Hsu,Chin Lin,Chiu-Ling Lai,Christopher P. Hess,Colin B. Compas,Deepeksha Bhatia,Eric K. Oermann,Evan Leibovitz,Hisashi Sasaki,Hitoshi Mori,Isaac Yang,Jae Ho Sohn,Krishna Nand Keshava Murthy,Li-Chen Fu,Matheus Ribeiro Furtado de Mendonça,Mike Fralick,Min Kyu Kang,Mohammad Adil,Natalie Gangai,Peerapon Vateekul,Pierre Elnajjar,Sarah E Hickman,Sharmila Majumdar,Shelley McLeod,Sheridan Reed,Stefan Gräf,Stephanie Harmon,Tatsuya Kodama,Thanyawee Puthanakit,Thanyawee Puthanakit,Tony Mazzulli,Tony Mazzulli,Vitor Lavor,Yothin Rakvongthai,Yu Rim Lee,Yuhong Wen,Fiona J. Gilbert,Mona Flores,Quanzheng Li +103 more
TL;DR: In this article, the authors used federated learning to predict future oxygen requirements of symptomatic patients with COVID-19 using inputs of vital signs, laboratory data and chest X-rays.
Journal ArticleDOI
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea
Seung Up Kim,Yeon Seok Seo,Han Ah Lee,Mi Na Kim,Yu Rim Lee,Hye Won Lee,Jun Yong Park,Do Young Kim,Sang Hoon Ahn,Kwang Hyub Han,Seong Gyu Hwang,Kyu Sung Rim,Soon Ho Um,Won Young Tak,Young Oh Kweon,Beom Kyung Kim,Soo-Young Park +16 more
TL;DR: The overall prognosis in terms of HCC and death or OLT was statistically not different between the ETV and TDF groups, and these findings were consistently reproduced in patients with compensated cirrhosis.
Journal ArticleDOI
Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study
Jung Gil Park,Won Young Tak,Soo-Young Park,Young Oh Kweon,Se Young Jang,Yu Rim Lee,Si Hyun Bae,Jae Young Jang,Do Young Kim,June Sung Lee,Ki Tae Suk,In Hee Kim,Heon Ju Lee,Woo Jin Chung,Byoung Kuk Jang,Jeong Ill Suh,Jeong Heo,Won Kee Lee +17 more
TL;DR: Long-term oral BCAA supplementation has beneficial effects in patients with advanced liver cirrhosis, and a further large-scale prospective study is needed to delineate these beneficial effects.
Journal ArticleDOI
Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis
Jeong Won Jang,Jong Young Choi,Young Seok Kim,Jeong-Ju Yoo,Hyun Young Woo,Sung Kyu Choi,Chung Hwan Jun,Chang Hyeong Lee,Joo Hyun Sohn,Won Young Tak,Yu Rim Lee,Kwang Hyub Han +11 more
TL;DR: In a 10‐year observation study of patients in Korea with HBV‐related decompensated cirrhosis, baseline MELD score and MVR to entecavir or lamivudine to associate with short‐ and long‐term transplant‐free survival is found.